Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Huber

Showing results (401-410 of 541) with videos related to

Pageof 55
Sort By:
Journal of Chemical Ecology|June 20, 2020
Local, Geographical, and Contextual Variation in the Aggregation Pheromone Blend of the Spruce Beetle, Dendroctonus rufipennis (Coleoptera: Curculionidae)R L Isitt, K P Bleiker, D S Pureswaran, et al.
Contributions to Nephrology|January 1, 1988
Treatment of polytransfused hemodialysis patients with recombinant human erythropoietinJ Bommer, W Huber, G Tewes, et al.
Hepatology (Baltimore, Md.)|April 1, 1997
Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regressionB Grasl-Kraupp, B Ruttkay-Nedecky, L Müllauer, et al.
Giornale Di Clinica Medica|November 1, 1975
[Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis]W Huber, G Previato, M Bertoli, et al.
Critical Reviews in Toxicology|February 19, 2000
Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic aminesC E Schwab, W W Huber, W Parzefall, et al.
Nutrition and Cancer|December 30, 2004
Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessmentSiegfried Knasmüller, Christophe Cavin, Asima Chakraborty, et al.
Contributions to Nephrology|November 2, 2001
The challenge of kidney lesions in von Hippel-Lindau diseaseH P Neumann, P Riegler, W Huber, et al.
Molecular Immunology|December 1, 1995
Variable region cDNA sequences and characterization of murine anti-human interferon gamma receptor monoclonal antibodies that inhibit receptor binding by interferon gammaA Bridges, A Birch, G Williams, et al.
Journal of Clinical Microbiology|April 16, 1999
Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissuesM Fischer, W Huber, A Kallivroussis, et al.
The Journal of Infectious Diseases|April 1, 1997
Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66H P Beck, I Felger, W Huber, et al.
Pageof 55

Showing results (401-410 of 541) with videos related to

Sort By:
Pageof 55
Journal of Chemical Ecology|June 20, 2020
Local, Geographical, and Contextual Variation in the Aggregation Pheromone Blend of the Spruce Beetle, Dendroctonus rufipennis (Coleoptera: Curculionidae)R L Isitt, K P Bleiker, D S Pureswaran, et al.
Contributions to Nephrology|January 1, 1988
Treatment of polytransfused hemodialysis patients with recombinant human erythropoietinJ Bommer, W Huber, G Tewes, et al.
Hepatology (Baltimore, Md.)|April 1, 1997
Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regressionB Grasl-Kraupp, B Ruttkay-Nedecky, L Müllauer, et al.
Giornale Di Clinica Medica|November 1, 1975
[Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis]W Huber, G Previato, M Bertoli, et al.
Critical Reviews in Toxicology|February 19, 2000
Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic aminesC E Schwab, W W Huber, W Parzefall, et al.
Nutrition and Cancer|December 30, 2004
Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessmentSiegfried Knasmüller, Christophe Cavin, Asima Chakraborty, et al.
Contributions to Nephrology|November 2, 2001
The challenge of kidney lesions in von Hippel-Lindau diseaseH P Neumann, P Riegler, W Huber, et al.
Molecular Immunology|December 1, 1995
Variable region cDNA sequences and characterization of murine anti-human interferon gamma receptor monoclonal antibodies that inhibit receptor binding by interferon gammaA Bridges, A Birch, G Williams, et al.
Journal of Clinical Microbiology|April 16, 1999
Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissuesM Fischer, W Huber, A Kallivroussis, et al.
The Journal of Infectious Diseases|April 1, 1997
Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66H P Beck, I Felger, W Huber, et al.
Pageof 55